Incyte Pins Hopes On Phase III Jakafi Analysis In COVID-19 ARDS

Phase III Overall Negative, But Successful On Subset And Post-Hoc Analyses

 
• By Alaric DeArment
  
Corona patient
Incyte hopes to gain an expanded access protocol for Jakafi in patients with COVID-19-associated ARDS • Source: Shutterstock
Scrip Podcast

Keep up with the top pharma business news of the week. On the go.

Scrip brings you a weekly bulletin of top picks.

SpotifyApple PodcastsWebsite

More from Business

More from Scrip